Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 7.91 is 59% above its 5-year average of 4.98, around the middle of its 5-year range (3.26–15.01).
As of the fiscal period ended Tuesday, June 30, 2026. 33.52% above its 12-month average of 5.92.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 7.91.
QUICK RATIO (ACID-TEST)
7.91
QUICK RATIO (ACID-TEST) AVG TTM
5.92
QUICK RATIO (ACID-TEST) AVG 3Y
4.61
QUICK RATIO (ACID-TEST) AVG 5Y
4.98
QUICK RATIO (ACID-TEST) AVG 10Y
5.35
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+33.52%
CURRENT VS 3Y AVG
+71.46%
CURRENT VS 5Y AVG
+58.67%
CURRENT VS 10Y AVG
+47.84%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+135.98%
vs the sector median at left
Arvinas, Inc.
Market Cap
$471.65M
Quick Ratio (Acid-Test)
7.91
TTM Avg
5.92
3Y Avg
4.61
5Y Avg
4.98
Market Cap
$471.57M
Quick Ratio (Acid-Test)
1.07
TTM Avg
1.48
3Y Avg
1.43
5Y Avg
1.74
Market Cap
$472.23M
Quick Ratio (Acid-Test)
121.97
TTM Avg
23.71
3Y Avg
19.95
5Y Avg
19.50
Market Cap
$469.12M
Quick Ratio (Acid-Test)
3.48
TTM Avg
3.42
3Y Avg
3.80
5Y Avg
5.13
Market Cap
$475.91M
Quick Ratio (Acid-Test)
37.17
TTM Avg
24.09
3Y Avg
19.47
5Y Avg
19.38
Market Cap
$465.75M
Quick Ratio (Acid-Test)
4.67
TTM Avg
9.07
3Y Avg
10.56
5Y Avg
11.63
Market Cap
$483.54M
Quick Ratio (Acid-Test)
2.64
TTM Avg
1.69
3Y Avg
1.64
5Y Avg
1.50
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Arvinas, Inc. (ARVN) | $471.65M | 7.91 | 5.92 | 4.61 | 4.98 |
| Cerus Corporation (CERS)vs › | $471.57M | 1.07 | 1.48 | 1.43 | 1.74 |
| Bright Minds Biosciences Inc. (DRUG)vs › | $472.23M | 121.97 | 23.71 | 19.95 | 19.50 |
| Alpha Teknova, Inc. (TKNO)vs › | $469.12M | 3.48 | 3.42 | 3.80 | 5.13 |
| Kamada Ltd. (KMDA)vs › | $467.90M | 2.29 | 2.21 | 1.73 | 2.24 |
| Contineum Therapeutics, Inc. (CTNM)vs › | $475.91M | 37.17 | 24.09 | 19.47 | 19.38 |
| Sight Sciences, Inc. (SGHT)vs › | $465.75M | 4.67 | 9.07 | 10.56 | 11.63 |
| Puma Biotechnology, Inc. (PBYI)vs › | $483.54M | 2.64 | 1.69 | 1.64 | 1.50 |
| Evolus, Inc. (EOLS)vs › | $486.01M | 1.28 | 1.88 | 1.90 | 1.89 |
| NRC Health (NRC)vs › | $452.54M | 0.65 | 0.55 | 0.77 | 1.10 |
Quick Ratio
7.91
Excludes inventory
Current Ratio
7.91
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 7.91 |
| 2026-03-31 | 5.44 |
| 2025-12-31 | 4.92 |
| 2025-09-30 | 5.70 |
| 2025-06-30 | 5.64 |
| 2025-03-31 | 4.58 |
| 2024-12-31 | 4.64 |
| 2024-09-30 | 4.17 |
| 2024-06-30 | 3.62 |
| 2024-03-31 | 4.94 |
| 2023-12-31 | 4.98 |
| 2023-09-30 | 3.26 |
| 2023-06-30 | 3.44 |
| 2023-03-31 | 4.06 |
| 2022-12-31 | 4.20 |
| 2022-09-30 | 5.33 |
| 2022-06-30 | 5.78 |
| 2022-03-31 | 6.12 |
| 2021-12-31 | 5.93 |
| 2021-09-30 | 8.64 |
| 2021-06-30 | 15.01 |
| 2021-03-31 | 16.46 |
| 2020-12-31 | 14.29 |
| 2020-09-30 | 6.53 |
| 2020-06-30 | 7.40 |
| 2020-03-31 | 8.15 |
| 2019-12-31 | 8.86 |
| 2019-09-30 | 6.79 |
| 2019-06-30 | 7.79 |
| 2019-03-31 | 8.72 |
| 2018-12-31 | 8.52 |
| 2018-09-30 | 4.81 |
| 2018-06-30 | 5.99 |
| 2018-03-31 | 6.63 |
| 2017-12-31 | 3.67 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
